CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,157,000 | +1006.2% | 526,210 | 0.0% | 0.02% | +950.0% |
| Q3 2016 | $195,000 | – | 526,210 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 526,210 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $279,000 | -50.8% | 526,210 | +14.1% | 0.00% | -57.1% |
| Q4 2015 | $567,000 | -20.9% | 460,999 | -6.1% | 0.01% | -22.2% |
| Q3 2015 | $717,000 | +8.1% | 490,999 | +44.3% | 0.01% | +12.5% |
| Q2 2015 | $663,000 | +147.4% | 340,237 | +126.0% | 0.01% | +166.7% |
| Q1 2015 | $268,000 | -62.3% | 150,569 | -50.0% | 0.00% | -40.0% |
| Q4 2014 | $710,000 | +95.1% | 301,138 | +100.0% | 0.01% | -16.7% |
| Q3 2014 | $364,000 | -23.2% | 150,569 | -10.7% | 0.01% | -33.3% |
| Q2 2014 | $474,000 | – | 168,537 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 191,000 | $345,710,000 | 0.34% |
| TFS CAPITAL LLC | 1,182,304 | $2,140,000 | 0.21% |
| TURNER INVESTMENTS LLC | 530,100 | $959,000 | 0.17% |
| DRW Securities, LLC | 486,953 | $881,000 | 0.14% |
| Candriam S.C.A. | 1,445,000 | $2,616,000 | 0.05% |
| First Heartland Consultants, Inc. | 74,624 | $135,000 | 0.05% |
| WASHINGTON TRUST Co | 410,616 | $743,000 | 0.05% |
| EAGLE ASSET MANAGEMENT INC | 4,332,630 | $7,842,000 | 0.04% |
| JW Asset Management, LLC | 52,271 | $95,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 702,571 | $1,272,000 | 0.03% |